Latest Entitlement Offer News

American Uranium Limited has kicked off a $2.59 million entitlement offer with free attaching options, aiming to accelerate drilling and studies at its flagship Lo Herma ISR Uranium Project. The updated timetable extends the offer period, while resource estimates remain stable.

Syrah Resources has closed its retail entitlement offer, securing A$61 million and pushing total equity raised to A$104 million. AustralianSuper’s stake will approach half the company as Syrah prepares to fund key projects and advance strategic funding talks.

KMD Brands has wrapped up a fully underwritten entitlement offer and placement, raising NZ$65.3 million to reduce net debt and shore up its balance sheet ahead of executing its growth plans.

Vintage Energy and Vault Energy have agreed to negotiate a gas sales deal for Cullen-1 gas, aiming to fuel modular data centres onsite if flow tests confirm commercial viability. Vintage plans to fund testing via farm-out once permit tenure is secured.

KMD Brands has secured NZ$11 million from its retail entitlement offer, with a 52% participation rate. The company now moves to clear a 169 million share shortfall through a retail bookbuild, while shares remain halted ahead of trading resumption.

Cosmo Metals is gearing up for a significant drilling campaign at its Kanowna Gold Project near Kalgoorlie, while systematic exploration at its NSW projects has revealed two high-priority copper-gold VMS targets. The company also bolstered its balance sheet with a $1.55 million entitlement offer to fund ongoing work.

Neometals has secured A$7.9 million through a placement and launched a concurrent A$5.1 million entitlement offer to fund gold production at Barrambie and advance lithium exploration in Utah. The capital raise supports a near-term production joint venture and aggressive resource expansion.

NEXTDC has boosted its pro forma contracted utilisation by 60% to 667MW, prompting a A$1.5 billion entitlement offer and an expanded capital plan to accelerate its Western Sydney data centre developments.

American Uranium (ASX:AMU) has kicked off a $2.58 million pro rata rights issue at a 3.1% discount to fund expansion drilling and technical studies at its flagship Lo Herma ISR Uranium Project ahead of a Q3 scoping study.

Neurizon Therapeutics has secured an additional A$2.7 million through a placement addressing the shortfall from its entitlement offer, lifting total proceeds to approximately A$8.5 million. This fresh capital strengthens the biotech’s balance sheet and provides financial flexibility as it advances its lead ALS drug NUZ-001 through pivotal clinical stages.

American Uranium has completed a A$2.64 million placement by issuing 22 million shares at A$0.12 each, aiming to fund drilling and technical studies at its Wyoming uranium projects.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing of its investigational drug PYC-001 for Autosomal Dominant Optic Atrophy from single to multiple doses, marking a key step in its clinical development.